BC cell-derived exosomes also stimulate bone marrow cell differentiation into MDSCs by downregulating CXCR4 expression and activating the STAT3 signaling pathway, which is closely associated with the drug resistance and poor prognosis of BC patients [78]. The gene discussed is CXCR4; the disease is breast cancer.